PMC:7601109 / 5061-5242
Annnotations
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T7480 | 0-1 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
| T18967 | 51-57 | http://purl.obolibrary.org/obo/UBERON_0000473 | denotes | tested |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T31 | 0-181 | Sentence | denotes | A large number of pharmacological agents are being tested as anti-sarcopenic agents such as bimagrumab (BYM338), enobasarm (GTx-024), trevogrumab (REGN1033), and sarconeos (BIO101). |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 112 | 92-102 | Chemical | denotes | bimagrumab | MESH:C000596367 |
| 113 | 104-110 | Chemical | denotes | BYM338 | MESH:C000596367 |
| 114 | 113-122 | Chemical | denotes | enobasarm | |
| 115 | 124-131 | Chemical | denotes | GTx-024 | MESH:C547106 |
| 116 | 134-145 | Chemical | denotes | trevogrumab | |
| 117 | 147-155 | Chemical | denotes | REGN1033 |